Deva Holding A.S. (IST:DEVA)

Market Cap	11.87B
Revenue (ttm)	14.70B
Net Income (ttm)	612.12M
Shares Out	200.02M
EPS (ttm)	n/a
PE Ratio	19.39
Forward PE	n/a
Dividend	0.29 (0.49%)
Ex-Dividend Date	Jun 25, 2024

Volume	635,413
Average Volume	474,601
Open	59.40
Previous Close	59.35
Day's Range	59.00 - 60.45
52-Week Range	53.55 - 106.00
Beta	-0.38
RSI	53.74
Earnings Date	Aug 15, 2025

About Deva Holding A.S.

Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, urinary syste...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1958
• Employees: 3,063
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: DEVA

Financial Performance

In 2024, Deva Holding A.S.'s revenue was 15.46 billion, a decrease of -5.50% compared to the previous year's 16.36 billion. Earnings were 69.42 million, a decrease of -98.58%.